You are here

abelacimab

Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate

Fierce Biotech

Tue, 02/11/25 - 11:42 am

Anthos Therapeutics

Anthos hails win over Xarelto with novel anticoagulant

Pharmaphorum

Mon, 09/18/23 - 09:56 am

Anthos Therapeutics

clinical trials

atrial fibrillation

Anthos doubles down on its novel blood thinner

EP Vantage

Fri, 01/27/23 - 10:34 am

Factor XI inhibitor

FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy

Pharmaceutical Business Review

Mon, 07/11/22 - 10:26 am

Anthos Therapeutics

Factor XI inhibitor